New Guidelines for Dopaminergic Therapy Set for Early Parkinson’s

New Guidelines for Dopaminergic Therapy Set for Early Parkinson’s

312284

New Guidelines for Dopaminergic Therapy Set for Early Parkinson’s

The American Academy of Neurology (AAN) has issued a new group of guidelines designed to aid clinicians in prescribing the most effective and appropriate dopaminergic medications — those that increase or mimic dopamine — to patients in the early stages of Parkinson’s disease. The new guidelines, endorsed by the Parkinson’s Foundation, were drafted after revision of the most updated information regarding dopaminergic medications, their efficacy, and side effects. “Choosing to start a medication is a…

You must be logged in to read/download the full post.